Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Net (2016 - 2021)

Viridian Therapeutics, Inc.\DE has reported Receivables - Net over the past 8 years, most recently at $1.0 million for Q3 2021.

  • Quarterly results put Receivables - Net at $1.0 million for Q3 2021, up 1654.39% from a year ago — trailing twelve months through Sep 2021 was $1.0 million (up 1654.39% YoY), and the annual figure for FY2019 was $6000.0, changed.
  • Receivables - Net for Q3 2021 was $1.0 million at Viridian Therapeutics, Inc.\DE, up from $57000.0 in the prior quarter.
  • Over the last five years, Receivables - Net for VRDN hit a ceiling of $4.8 million in Q1 2018 and a floor of $4000.0 in Q1 2020.
  • Median Receivables - Net over the past 5 years was $500000.0 (2017), compared with a mean of $853000.0.
  • Biggest five-year swings in Receivables - Net: soared 7180.0% in 2017 and later crashed 99.88% in 2019.
  • Viridian Therapeutics, Inc.\DE's Receivables - Net stood at $1.5 million in 2017, then crashed by 98.35% to $24000.0 in 2018, then soared by 3979.17% to $979000.0 in 2019, then crashed by 94.18% to $57000.0 in 2020, then skyrocketed by 1654.39% to $1.0 million in 2021.
  • The last three reported values for Receivables - Net were $1.0 million (Q3 2021), $57000.0 (Q3 2020), and $248000.0 (Q2 2020) per Business Quant data.